| Previous Close | 6.25 |
| Open | 5.76 |
| Bid | 5.80 x 1100 |
| Ask | 6.36 x 4200 |
| Day's Range | 5.76 - 5.76 |
| 52 Week Range | 4.36 - 8.12 |
| Volume | 101 |
| Avg. Volume | 1,131 |
| Net Assets | 908.98k |
| NAV | 5.84 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Return | -24.04% |
| Beta (3y) | 0.60 |
| Expense Ratio (net) | 0.75% |
| Inception Date | 2008-06-24 |
- Zacks•4 months ago
The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, Global X MSCI Argentina, iPath S&P 500 VIX Short-Term Futures, iPath Bloomberg Natural Gas Subindex Total Return and iPath Global Carbon
The Zacks Analyst Blog Highlights: BioShares Biotechnology Clinical Trials, Global X MSCI Argentina, iPath S&P 500 VIX Short-Term Futures, iPath Bloomberg Natural Gas Subindex Total Return and iPath Global Carbon
- Zacks•4 months ago
Best and Worst Zones of Q1 and Their ETFs
Most corners of ETF investing have performed exceptionally well in Q1 while a few areas are lagging.
- Investopedia•4 months ago
Best and Worst Zones of Q1 and Their ETFs
The rally in the global stock market continued with Trump-fueled optimism and expectation of faster growth. In fact, stocks scaled multiple highs on several occasions in the first quarter amid bouts of ...
